Press Releases AC Immune SA

Equities

ACIU

CH0329023102

Market Closed - Nasdaq Other stock markets 04:00:00 2024-07-11 pm EDT			5-day change	1st Jan Change
3.55 ^USD	+2.90%		-6.82%	-29.00%

May. 31	BTIG Starts AC Immune With Buy Rating, $8 Price Target	MT
May. 13	Sector Update: Health Care Stocks Mixed Late Afternoon	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

AC Immune to Present at the Jefferies Global Healthcare Conference in June 2024	May. 28	AQ
Takeda agrees to develop active immunotherapy for Alzheimer's	May. 14	AQ
AC Immune: Q1 Earnings Snapshot	May. 13	AQ
AC Immune Reports First Quarter 2024 Financial Results and Provides a Corporate Update	May. 13	AQ
AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer’s Disease	May. 13	AQ
AC Immune Reports Full Year 2023 Financial Results and Provides a Corporate Update	Mar. 14	AQ
AC Immune Announces Upcoming Presentations at AD/PD™ 2024	Feb. 22	AQ
AC Immune to Regain Global Rights to Crenezumab and Semorinemab	Jan. 22	AQ
AC Immune Progress Update on Phase 2 Active Immunotherapy Clinical Pipeline for Alzheimer's and Parkinson diseases	Jan. 03	AQ
AC Immune : Underwriting Agreement - Form 6-K	Dec. 19	PU
AC Immune's Targeted Anti-PTau Active Immunotherapy for Alzheimer's disease Advances into Phase 2b Trial	Dec. 18	AQ
AC Immune Announces Pricing of Underwritten Offering of Common Shares	Dec. 18	AQ
AC Immune Announces Pricing of Underwritten Offering of Common Shares	Dec. 15	AQ
AC Immune’s Targeted Anti-pTau Active Immunotherapy for Alzheimer’s Disease Advances into Phase 2b Trial	Dec. 15	AQ
AC Immune Strengthens Management, Appoints Madiha Derouazi as CSO and Christopher Roberts as CFO	Dec. 04	AQ
AC Immune Strengthens Management, Appoints Madiha Derouazi as CSO and Christopher Roberts as CFO	Dec. 01	AQ
Women in Stem with Andrea Pfeifer	Nov. 30	AQ
AC Immune to Present at the Jefferies 2023 London Healthcare Conference	Nov. 07	AQ
AC Immune: Q3 Earnings Snapshot	Nov. 03	AQ
AC Immune Reports Third Quarter 2023 Financial Results and Provides a Corporate Update	Nov. 03	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases AC Immune SA

Equities

ACIU

CH0329023102

Press Releases

Filters